November 20, 2017 / 10:58 PM / a month ago

BRIEF-Quest Diagnostics provides update on impact of 2018 Medicare payment rates

Nov 20 (Reuters) - Quest Diagnostics Inc:

* Quest Diagnostics provides update on impact of final 2018 Medicare payment rates for clinical laboratory tests

* Quest Diagnostics Inc - ‍expects impact of final fee schedule rates under Protecting Access To Medicare Act​ (PAMA) to be about 4% in 2018

* Quest Diagnostics Inc - ‍expects impact of final fee schedule rates under PAMA to be about 10% in 2019 and 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below